Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(2)
About
Glenmark Pharmaceuticals Ltd.
NSE: GLENMARK
|
BSE: 532296
|
ISIN: INE935A01035
|
Industry: Pharmaceuticals
|
Mid-range Performer
1590.2000
5.40
(
0.34
%)
NSE
Jun 06, 2025
15:31 PM
34.48% Gain from 52W Low
Volume:
940.3K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Glenmark Pharmaceuticals Ltd.
14 Aug 2023
1590.20
0.34%
EU/ROW markets and operating leverage drive profitability
Neutral:
Glenmark Pharmaceuticals Ltd.
by
Motilal Oswal
Target: 780
Target
Motilal Oswal
Glenmark Pharmaceuticals Ltd. is trading above all available SMAs
More from Glenmark Pharmaceuticals Ltd.
Recommended
Five Interesting Stocks Today - June 06, 2025
The Baseline |
06 Jun 2025, 05:45PM
Market closes higher, RBI’s MPC slashes the Cash Reserve Ratio from 4% to 3%
Trendlyne Marketwatch |
06 Jun 2025, 03:56PM
Earnings Call Transcript - Q4FY20 for Glenmark Pharmaceuticals
|
29 Jun 2020